NCPIE CMI Initiative. Criteria Committee Members American Society of Health-System Pharmacists Catalina Marketing Cerner Multum First DataBank Medical.

Slides:



Advertisements
Similar presentations
Enhancing Written Information from the Pharmacy: An Update on MedGuides & Consumer Medicine Information (CMI) National Association of Chain Drug Stores.
Advertisements

Labeling Prescription Drugs for Physicians and Consumers 48 th Annual Conference Preparing for the Next Century of Food and Drug Regulation Food and Drug.
NCPIE CMI Initiative. Education Committee Members American Pharmacists Association First DataBank National Assn. of Boards of Pharmacy National Assn.
NCPIE CMI Initiative. Goals Letter of the Law –Fulfill promise of the Keystone process Spirit of the Law –Provide useful information for low literate.
NCPIE CMI Initiative. Implementation Cmte. Members American Society for Automation in Pharmacy Catalina Marketing Merck Research Labs National Community.
Common/shared responsibilities between jobs.
Why documentation is relevant in implementing the NMP Dr Ross Maxwell Member, National Medicines Policy Committee Session 5: The Relevance of National.
5th Annual PBM Pharmacy Informatics Conference
Introduction to Drug Information Services Ch.#1. An introductory course to teach the students basic principles of DI retrieval. Designed to help students.
The Brain - Challenges 1. Relationship Dynamics/Kinetics - Challenges 2.
REMS Update NORD Corporate Council Meeting May 14, 2013
RADPEER™ Hani Abujudeh MD, MBA, FSIR Associate Professor of Radiology
INSTITUTIONAL PHARMACY PRACTICE STANDARDS
Dr. Dalal AL-Matrouk KBA Farwaniya Hospital
PHCL 328: Introduction to Drug and Poison Information
Comparison: Traditional vs. Outcome Project Evaluative Processes Craig McClure, MD Educational Outcomes Service Group University of Arizona December 2004.
Management of Communication and Information Chapter -MCI
Anne Burns, RPh Group Director, Practice Development and Research
April 8, 2005FDLI Annual Conference 1 Labeling Prescription Drugs for Physicians and Consumers (FDA Perspective) Paul J. Seligman, MD, MPH Director, Office.
Prescription Drug Information for Patients: History
Standard 4: Medication Safety Advice Centre Network Meeting Margaret Duguid Pharmaceutical Advisor February 2013.
Presented by Vicki M. Young, PhD October 19,
Accelerating Progress in Promoting Prescription Medicine Adherence: The Adherence Action Agenda Presented by: Ray Bullman National Council on Patient Information.
1. How can we promote pharmacies and the full service available? Think about: How the NHS works with Local Authorities to enhance the role of community.
American College of Cardiology Transforming Science into Quality Care.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
Pharmacy Practice Introduction
An Introduction to the National Lipid Association Presented by: Insert Date.
EPHA EGM 2/12/2002 A definition of health A state of complete physical, mental and social well-being and not merely the absence of disease or infirmity.
1 European Health Forum Gastein Lunch Workshop 1 6 October 2005 What do the patients expect from health professionals? Rod Mitchell, Chairman European.
Clinical Pharmacy Part 2
And patient empowerment Renate Heinisch, Rapporteur EESC.
Standard 4: Medication Safety Advice Centre Network Meeting Margaret Duguid Pharmaceutical Advisor February 2013.
FDA Risk Management Workshop: Concept Paper: Risk Management Programs April 10, 2003 Gary C. Stein, Ph.D. Director of Federal Regulatory Affairs American.
You can make health services healthier Health Care Consumers’ Association of the ACT Inc.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
Documentation of Care Provided Patient’s care - who should do it? WHY DOCUMENT? When should it occur? Where should it be documented? How should it be documented?
Fiancee Lee A. Banzon RPh.RN.  P harmacists practicing today in the Philippines or other developed or developing countries will interact with technology.
Medication Error Reduction Principles in Practice Copyright © – Academy of Managed Care Pharmacy (AMCP)Slide 1.
Pharmacists Perceptions of the Development of Herbal Medicines in Iran
Resident Self Assessment Where do you fall on the continuum for each of the following? Please make an “X” on each line then date it: History Novice Advanced.
Medical Professionalism
“What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.
TOWARDS RECOVERY CLINICS Patient Care. Community Fit. An Integrated Approach to Comprehensive Treatment.
Pharmacy is not less important than medicine
Performance Measurement & Public Reporting: Consumer Perspective and Principles To schedule a presentation of “Performance Measurement & Public Reporting”
Sara Lovell, CPCS Education Coordinator Providence Alaska Medical Center.
AFAMS Provide a Filled Medication (Dari) EO
Drug Information Services. Aims of the Course To introduce the students how to locate, evaluate drug information’s systematically, manage and distribute.
July 15, Postmarketing Safety Evaluation of Approved Drugs and Risk Management Victor F. C. Raczkowski, MD, MS Director, Office of Drug Safety July.
Resident Self Assessment Where do you fall on the continuum for each of the following? Please make an “X” on each line then date it: History Novice Advanced.
1 Presentation of the Pharmaceutical Research and Manufacturers of America at FDA Part 15 Hearing on Communication of Drug Safety Information December.
Evaluating Consumer Comprehension of Prescription Drug Information Saul Shiffman, Ph.D. Senior Scientific Advisor, Pinney Associates Consulting to industry.
Sharing and Learning. Our team members:  Physicians, MOAs, other staff One Chronic Pain Patient:  Male/female  Age  Occupation  Main complaint 
History of FDA Consumer Information About Prescription Drugs Thomas J. McGinnis, R.Ph. July 17, 2002.
Quality Control Dr. Waddah D’emeh. Controlling Fifth and final step of the management process. Performance is measured against predetermined standards.
Government Regulatory Agencies and Impact on Consumer Choices Presentation.
Useful Medication Information for Consumers Gerald K. McEvoy, Pharm.D. Assistant Vice President, Drug Information Editor in Chief, AHFS Drug Information.
Developing role of community pharmacy in responding to the needs of people with drug problems Karen Melville Principal Pharmacist TSMS NHS Tayside.
GB.DRO f, date of preparation: January 2010 Dartford and Gravesham NHS Trust Pharmacy Services in Hospital.
 Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and.
Kings Specialty Pharmacy Services in Brooklyn
Efficacy and Safety of Medicines
Innovation for Healthier Americans
Risk Communication in Medicines
Evaluating Learners Jennifer L. Middleton, MD, MPH, FAAFP
The Foundation of Pharmaceutical Care
Hospital pharmacy.
Additional Run Chart or SPC chart if needed
Presentation transcript:

NCPIE CMI Initiative

Criteria Committee Members American Society of Health-System Pharmacists Catalina Marketing Cerner Multum First DataBank Medical Care & Outcomes National Community Pharmacists Assn. National Consumers League WoltersKluwer Health Clinical Tools Div.

NCPIE CMI Initiative Criteria Committee Unless Consumer Medicine Information helps patients use medicine safely and effectively, the information is of little value. This committees role is to ensure that patients receive truly useful CMI.

NCPIE CMI Initiative Criteria Cmte. Role & Mission Provide advice on whats considered useful based on Keystone criteria Translate Keystone criteria into concrete requirements: (1) Develop/apply principles to help apply criteria to specific medicines; (2) Develop therapeutic-class prototypes

NCPIE CMI Initiative Challenge: Clash of Criteria Fully comprehensive CMI may not be easily understood by patients Rely on consumer research to assess variety of CMI formats effect on consumer understanding, appropriate utilization of medicines, etc.

NCPIE CMI Initiative Practical Issues to Overcome Professional sources of information (beyond package insert) to determine scientific accuracy Legibility (font size) vs. pharmacy system integrators single pass technology

NCPIE CMI Initiative Development of Scoring Method Criteria Cmte. will address what constitutes a passing grade for individual criteria, and/or collectively for all criteria? Use objective consumer research to better understand how CMI criteria influence usefulness

NCPIE CMI Initiative Criteria Committee Process Balanced makeup Study translational principles – applied to all medicines

NCPIE CMI Initiative Criteria Cmte. & FDA Input Whatever criteria applications are developed must be acceptable to FDA FDA input into design and acceptability of criteria will be invited FDA advice on specific info to include in CMI leaflet, and on information sources to develop clinically-accurate information, will also be sought